Maria Siemionow
Founder at Dystrogen Therapeutics Corp.
Maria Siemionow active positions
| Companies | Position | Start | End |
|---|---|---|---|
Dystrogen Therapeutics Corp.
 Dystrogen Therapeutics Corp. Packaged SoftwareTechnology Services Dystrogen Therapeutics Corp. develops platform for therapies of rare genetic diseases. The company was founded by Kris Siemionow, Maria Siemionow, and Paul Lewicki in 2017 and is headquartered in Chicago, IL. | Chief Tech/Sci/R&D Officer | 01/01/2017 | - |
| Founder | 01/01/2017 | - |
Career history of Maria Siemionow
Former positions of Maria Siemionow
| Companies | Position | Start | End |
|---|---|---|---|
Tolera Therapeutics, Inc.
 Tolera Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tolera Therapeutics, Inc. develops novel therapies and technologies for immune modulation. Its products include anti-aßTCR antibody an immune induction therapy in solid organ transplantation and graft versus host disease. The company was founded by Jake Orville, Maria Siemionow, James J. Herrmann and John J. Puisis in 2007 and is headquartered in Ann Arbor, MI. | Chief Tech/Sci/R&D Officer | 20/09/2010 | - |
| Founder | 20/09/2010 | - |
Statistics
International
| United States | 3 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
Sectoral
| Commercial Services | 2 |
| Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Tolera Therapeutics, Inc.
Tolera Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tolera Therapeutics, Inc. develops novel therapies and technologies for immune modulation. Its products include anti-aßTCR antibody an immune induction therapy in solid organ transplantation and graft versus host disease. The company was founded by Jake Orville, Maria Siemionow, James J. Herrmann and John J. Puisis in 2007 and is headquartered in Ann Arbor, MI. | Commercial Services |
Dystrogen Therapeutics Corp.
Dystrogen Therapeutics Corp. Packaged SoftwareTechnology Services Dystrogen Therapeutics Corp. develops platform for therapies of rare genetic diseases. The company was founded by Kris Siemionow, Maria Siemionow, and Paul Lewicki in 2017 and is headquartered in Chicago, IL. | Technology Services |
- Stock Market
- Insiders
- Maria Siemionow
- Experience
